AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

auro pharma inc🇨🇦 Health Canada

Approval Id: 46cb2aa883dfd6a2
Drug Approval Canada Name: AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
Product Name: AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
Status: Marketed
Status Date: 2020-03-18
Original Market Date: 2020-03-18
Din: 02478404
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.16
Atc Original: J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ
Atc Name: j 05 ar 06
Aig Number: 0352327001
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

EFAVIRENZ

600 MG

EMTRICITABINE

200 MG

TENOFOVIR DISOPROXIL FUMARATE

300 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

46cb2aa883dfd6a2

Type

Standard